As stated by the American Heart Association, high cholesterol is one of the major controllable risk factors for coronary heart disease, heart attack, and stroke. As your blood cholesterol levels rise, risk for coronary heart disease increase as well, especially if a person has some of the other risk factors for heart disease, such as high blood pressure or diabetes. A person with high cholesterol does not exhibit any symptoms and knowing total blood cholesterol levels can be an important first step in recognizing and mitigating a person's risk for a heart attack or stroke.
iMPak Health has developed a credit card sized test for easy and convenient screening for total cholesterol and trigylceride levels - an important first step in empowering people to better understand their risks and seek medical advice for managing their cholesterol levels. By placing a small blood sample on the card, the innovative chip and communication design allows for testing and storage of the information right on the card. Once the test is complete, people will be able to download their readings by simply placing the Cholesterol Screening Card next to their NFC enabled cell phone or an NFC reader connected to their personal computer. While placing this highly sophisticated lab capability on a small chip that can be distributed to the masses is a phenomenal innovation, iMPak Health's goal is to further enhance the technology to provide LDL (bad cholesterol) and HDL (good cholesterol) levels to provide more detailed information for self and provider based health management.
According to the American Heart Association, approximately 4.3 million Americans have some sort of arrhythmia with the most common, atrial fibrillation, representing close to 50% at 2.2 million. About 70% of those with atrial fibrillation are between the ages of 65 and 85 years of age and it is a common reason for admission to the hospital among this age group. iMPak Health has developed a unique, post diagnosis program to help patients and clinicians better document specific symptoms when the patient may feel symptomatic with our RhythmTrak card, which is a handheld ECG device that can document waveforms and calculate R to R intervals. In addition, patients can document symptoms of fatigue or other symptoms through the use of an electronic journal. Data is shared with the physician to determine if signs and symptoms have significantly changed requiring more intensive medication therapy or diagnostic study.
High Blood Pressure (HBP) affects almost one in three adults and is a major risk factor for many conditions such as heart disease, stroke, congestive heart failure, as well as kidney failure. While there are many medications to help manage HBP, there are many factors involved in optimum management such as routine and frequent BP readings to better monitor patient response to treatment. In addition, medication compliance, a heart healthy diet, and exercise are crucial elements to a complete program. iMPak Health has developed Heart Health Food Journals to help build compliance with healthy food choices, easy to use pedometers to track activity levels, and medication compliance tools to help track compliance with treatment regimes. However, an easy to use tool, portable device to measure and track BP readings is soon to be added to the product portfolio as well.
Congestive heart failure, or chronic heart failure, is a serious condition that is responsible for most hospital admissions for people over the age of 60. Once a patient has been diagnosed with heart failure, many lifestyle changes are necessary to manage the severity of the condition and its progression. Many of these lifestyle changes include managing weight, food choices, sodium intake, and closely monitoring daily fluid intake and output.
iMPak Health has developed a daily journal for patients to document their daily activities, track their symptoms, food intake, and compliance with medications. Being able to document and track these key pieces of data are critical in the clinicians approach to guiding the patient in self-care as well as the medical management of the condition. The addition of a medication compliance device enables iMPak Health to enable clinicians to a new set of tools to help manage this chronic condition while engaging patients in their own care in a very different way.